The panel explores how biotech companies can implement efficient, inspection-ready and compliance-driven Quality Management Systems (QMS) without unnecessary complexity. Experts from regulatory, operational, and quality assurance will share insights on tailoring QMS, balancing compliance and agility, and avoiding common pitfalls. Attendees will gain actionable takeaways on risk-based approaches and best practices to build a robust yet flexible QMS.
May 6, 14:00-14:45, room Marriott 3+4+5
| Name | Position | Institution |
|---|---|---|
| Arnaud Levain Chavanon | Managing Director | ObelysQ SA |
| Name | Position | Institution |
|---|---|---|
| Ludovic Moulin | Managing Director | ObelysQ SA |
| Clare Price | VP Clinical Operations | CDR-Life |
| Debora Schmitz-Rohmer | Head of Development | T3 Pharma |
| Dr. Kirsten Leidreiter | Head of Clinical study Assessor | Swissmedic |
ObelysQ is a leading consulting firm offering tailored solutions to the pharma industry aiming at enhancing compliance and improving processes in the execution of clinical trials. Our Headquarters are in Neuchâtel, with a branch in Poland and upcoming expansion to the US.
